FABP1

Across TCGA pan-cancer cohorts, FABP1 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated FABP1 data layer compared with 22 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher FABP1 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated FABP1 expression acts as an unfavorable survival marker, although some lineages such as CCRCC and PDAC show a favorable association.

CCRCC, PDAC, and LUAD are the cancer types where FABP1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	OS	Quartile	All	1.000	0.703	.001	30	view →
PDAC	DFS	Quartile	All	0.654	0.305	<.001	25	view →
LUAD	DFS	Median	II,III,IV	0.275	0.611	.007	21	view →
COAD	DFS	Median	IV	1.000	0.605	.043	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

FABP1–CCRCC (OS)

Open the CCRCC breakdown →